These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2136389)

  • 41. Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type.
    Haxby JV; Grady CL; Koss E; Horwitz B; Heston L; Schapiro M; Friedland RP; Rapoport SI
    Arch Neurol; 1990 Jul; 47(7):753-60. PubMed ID: 2357155
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Different cerebral metabolism between parkinsonian rigidity and hyperkinesia (DID, chorea, dystonia). A PET study.
    Hirato M; Horikoshi S; Kawashima Y; Satake K; Shibazaki T; Ohye C
    Adv Neurol; 1993; 60():511-4. PubMed ID: 8420180
    [No Abstract]   [Full Text] [Related]  

  • 43. Age-associated memory loss: initial neuropsychological and cerebral metabolic findings of a longitudinal study.
    Small GW; Okonek A; Mandelkern MA; La Rue A; Chang L; Khonsary A; Ropchan JR; Blahd WH
    Int Psychogeriatr; 1994; 6(1):23-44; discussion 60-2. PubMed ID: 8054492
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional basis of memory impairment in multiple sclerosis: a[18F]FDG PET study.
    Paulesu E; Perani D; Fazio F; Comi G; Pozzilli C; Martinelli V; Filippi M; Bettinardi V; Sirabian G; Passafiume D; Anzini A; Lenzi GL; Canal N; Fieschi C
    Neuroimage; 1996 Oct; 4(2):87-96. PubMed ID: 9345500
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Positron emission tomography in the study of brain metabolism in psychiatric and neuropsychiatric disorders.
    Bench CJ; Dolan RJ; Friston KJ; Frackowiak RS
    Br J Psychiatry Suppl; 1990; (9):82-95. PubMed ID: 2291823
    [No Abstract]   [Full Text] [Related]  

  • 46. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
    McGeer PL; Kamo H; Harrop R; Li DK; Tuokko H; McGeer EG; Adam MJ; Ammann W; Beattie BL; Calne DB
    CMAJ; 1986 Mar; 134(6):597-607. PubMed ID: 3512063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia.
    Koss E; Friedland RP; Ober BA; Jagust WJ
    Am J Psychiatry; 1985 May; 142(5):638-40. PubMed ID: 3872604
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Positron emission tomography in degenerative dementias.
    Salmon E; Franck G
    Acta Neurol Belg; 1989; 89(3-4):150-5. PubMed ID: 2516961
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional brain imaging of a catatonic type of schizophrenia: PET and SPECT studies.
    Satoh K; Narita M; Someya T; Fukuyama H; Yonekura Y
    Jpn J Psychiatry Neurol; 1993 Dec; 47(4):881-5. PubMed ID: 8201798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gliomatosis cerebri: disconnection of the cortical grey matter, demonstrated on PET scan.
    Plowman PN; Saunders CA; Maisey MN
    Br J Neurosurg; 1998 Jun; 12(3):240-4. PubMed ID: 11013687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Positron emission tomography with [18F]fluorodeoxyglucose differentiates normal pressure hydrocephalus from Alzheimer-type dementia.
    Jagust WJ; Friedland RP; Budinger TF
    J Neurol Neurosurg Psychiatry; 1985 Nov; 48(11):1091-6. PubMed ID: 3878390
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determinations of cerebral glucose utilization in dementia using positron emission tomography.
    Kuhl DE; Metter EJ; Riege WH; Hawkins RA
    Dan Med Bull; 1985 Feb; 32 Suppl 1():51-5. PubMed ID: 3872772
    [No Abstract]   [Full Text] [Related]  

  • 53. Towards a behavioral typology of Alzheimer's patients.
    Martin A; Brouwers P; Lalonde F; Cox C; Teleska P; Fedio P; Foster NL; Chase TN
    J Clin Exp Neuropsychol; 1986 Oct; 8(5):594-610. PubMed ID: 3492510
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regional brain glucose metabolism: correlations to biochemical measures and anxiety in patients with schizophrenia.
    Wik G; Wiesel FA
    Psychiatry Res; 1991 Oct; 40(2):101-14. PubMed ID: 1722339
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cortical metabolism in posterolateral thalamic stroke: PET study.
    Chabriat H; Pappata S; Levasseur M; Fiorelli M; Tran Dinh S; Baron JC
    Acta Neurol Scand; 1992 Sep; 86(3):285-90. PubMed ID: 1414249
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic dementia in Parkinson's disease treated by anticholinergic agents. Neuropsychological and neuroradiological examination.
    Nishiyama K; Mizuno T; Sakuta M; Kurisaki H
    Adv Neurol; 1993; 60():479-83. PubMed ID: 8420174
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human cerebral metabolism: studies in normal subjects and patients with dementia and amnesia.
    Mazziotta JC
    Ann N Y Acad Sci; 1985; 444():269-86. PubMed ID: 3160282
    [No Abstract]   [Full Text] [Related]  

  • 58. Positron emission tomography in dementia of the Alzheimer type. A brief review with a case study.
    Berg G; Grady CL; Sundaram M; Haxby JV; Moore AM; White J; Heston L; Rapoport SI; Avioli LV
    Arch Intern Med; 1986 Oct; 146(10):2045-9. PubMed ID: 3490239
    [No Abstract]   [Full Text] [Related]  

  • 59. Reduced regional brain glucose metabolism assessed by positron emission tomography in electrodermal nonresponder schizophrenics: a pilot study.
    Hazlett EA; Dawson ME; Buchsbaum MS; Nuechterlein KH
    J Abnorm Psychol; 1993 Feb; 102(1):39-46. PubMed ID: 8436698
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diminished cerebral metabolic response to motor stimulation in schizophrenics: a PET study.
    Guenther W; Brodie JD; Bartlett EJ; Dewey SL; Henn FA; Volkow ND; Alper K; Wolkin A; Cancro R; Wolf AP
    Eur Arch Psychiatry Clin Neurosci; 1994; 244(3):115-25. PubMed ID: 7803524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.